Related Experiment Video
Updated: Jun 15, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
FXN targeting induces cell death in ovarian cancer stem-like cells through PRDX3-Mediated oxidative stress
Shanshan Xu1, Yuwan Liu2, Shizhou Yang1
1Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, Zhejiang, China.
Abstract:
Ovarian cancer stem cells (OCSCs) significantly impact the prognosis, chemoresistance, and treatment outcomes in OC. While ferroptosis has been proven effective against OCSCs, the intricate relationship between ferroptosis and OCSCs remains incompletely understood. Here, we enriched ovarian cancer stem-like cells (OCSLCs) through mammosphere culture, as an OCSC model. OCSLCs displayed heightened ferroptosis susceptibility, correlating with elevated FXN levels compared to non-stem OC cells. FXN has recently emerged as a potential regulator in ferroptosis. FXN knockdown diminished stemness marker nanog, sphere-forming ability, increased reactive oxygen species (ROS) generation, and attenuated OCSLCs viability. FXN overexpression exacerbated ferroptosis resistance and reduced RSL3-induced cell death. FXN knockdown impeded OCSLC xenograft tumor growth and exacerbated the degeneration of peroxiredoxin 3 (PRDX3), a mitochondrial antioxidant protein participates in oxidative stress. Thus, elevated FXN in OCSLCs suppresses ROS accumulation, fostering ferroptosis resistance, and regulates the antioxidant protein PRDX3. FXN emerges as a potential therapeutic target for OC.
Insights
Elevated FXN in ovarian cancer stem cells (OCSCs) promotes ferroptosis resistance by suppressing reactive oxygen species (ROS). Targeting FXN may offer a new therapeutic strategy for ovarian cancer (OC).
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Ovarian cancer stem cells (OCSCs) are crucial in ovarian cancer (OC) progression, chemoresistance, and poor prognosis.
- Ferroptosis is a promising therapeutic strategy against OCSCs, but its regulation by OCSCs is not fully understood.
Purpose of the Study:
- To investigate the role of Frataxin (FXN) in ferroptosis regulation within ovarian cancer stem-like cells (OCSLCs).
- To explore FXN as a potential therapeutic target for ovarian cancer.
Main Methods:
- Enrichment of OCSLCs using mammosphere culture.
- Assessment of ferroptosis susceptibility, stemness markers (Nanog), sphere-forming ability, reactive oxygen species (ROS) levels, and cell viability.
- FXN knockdown and overexpression studies.
- Evaluation of OCSLC xenograft tumor growth and peroxiredoxin 3 (PRDX3) levels.
Main Results:
- OCSLCs exhibit higher ferroptosis susceptibility linked to elevated FXN levels.
- FXN knockdown reduces stemness, sphere formation, and OCSLC viability while increasing ROS.
- FXN overexpression confers ferroptosis resistance.
- FXN knockdown inhibits tumor growth and affects PRDX3, a key antioxidant protein.
Conclusions:
- Elevated FXN in OCSLCs suppresses ROS accumulation, conferring resistance to ferroptosis.
- FXN plays a critical role in regulating OCSC stemness and ferroptosis resistance.
- FXN represents a potential therapeutic target for overcoming chemoresistance in ovarian cancer.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Oogenesis
The Intrinsic Apoptotic Pathway

